SC 13G

Company

AEON Biopharma, Inc.

Filed

November 14, 2024

Accession Number

0001140361-24-046966

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →